MPP+, the active metabolite of MPTP, induces selective mitochondrial dysfunction and oxidative stress by entering dopaminergic neurons via DAT and disrupting mitochondrial complex I, making it a well-established in vitro model for studying PD-related neurotoxicity [28]. Here, SLC6A3 is linked to Parkinson disease.